Tvardi Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TVRD | TRAW | GTBP | GRI | NIKI | TVGN | |
|---|---|---|---|---|---|---|
| Market cap | 11.49M | 4.13M | 9.98M | 3.13M | 5.27M | 95.87M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.4 | -0.1 | -0.4 | -0.7 | — | — |
| Price/book | 1.0 | 2.4 | 2.4 | 0.3 | 0.1 | -1.4 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −80.21% | −86.70% | −65.05% | −97.10% | −87.62% | −77.45% |
| Today | +3.17% | −11.06% | −8.16% | −7.14% | −3.98% | −3.38% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All TVRD news ›Tvardi Therapeutics (NASDAQ:TVRD) Stock Bumped Up to “Sell” by Wall Street Zen
Posted by Sarita Garza on Oct 25th, 2026 Wall Street Zen upgraded shares of Tvardi Therapeutics (NASDAQ:TVRD – Free Report) from a strong sell rating to a sell rating in a research note released on Saturday morning,Wall Street Zen reports.…
Tvardi Therapeutics to Participate in Chardan’s 10th Annual Healthcare Conference
A phase 1b/2 clinical trial is an early-stage human study that combines the objectives of a phase 1b trial (refining dose, schedule and initial safety or tolerability in a target patient population) with those of a phase 2 trial…
Tvardi Therapeutics (NASDAQ:TVRD) and Astrazeneca (NYSE:AZN) Critical Review
Posted by Defense World Staff on Oct 8th, 2026 Astrazeneca (NYSE:AZN – Get Free Report) and Tvardi Therapeutics (NASDAQ:TVRD – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- defenseworld.net1
- globenewswire.com1
- stocktitan.net1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.